Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Feb;111(4):431-3.
doi: 10.1172/JCI17862.

Oxidative stress and diabetic neuropathy: a new understanding of an old problem

Affiliations
Review

Oxidative stress and diabetic neuropathy: a new understanding of an old problem

Eva L Feldman. J Clin Invest. 2003 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms leading to neuronal degeneration in hyperglycemia involve reactive oxygen species (ROS) formation. The diabetic state produces impaired neurotropism, axonal transport and gene expression through at least four major pathways. 1) Excess glucose is diverted away from glycolysis by the polyol pathway that depletes NADPH and cellular antioxidant capacity. 2) Glucose also may become oxidized and form AGEs that alter extracellular matrix, activate receptors that produce ROS intermediates, and alter intracellular protein function. 3) PKC becomes activated either directly by glycolytic intermediates or indirectly as shown as a second messenger for stress hormones, leading to increased vascular disease, inflammation, and oxidative stress. 4) Partial glycolysis causes accumulation of glycolytic intermediates and leads to escape of fructose-6-phosphate along the hexosamine pathway that increases vascular disease and further ROS generation. These mechanisms are ultimately linked to superoxide production through increased glucose respiration that produces superoxide in the mitochondria and also activates the superoxide-producing NADH oxidase. GSSG, glutathione disulfide; TCA, tricarboxylic acid cycle.

Comment on

References

    1. Windebank, A.J., and Feldman, E.L. 2001. Diabetes and the nervous system. In Neurology and general medicine. M.J. Aminoff, editor. Churchill Livingstone. Philadelphia, Pennsylvania, USA. 341–364.
    1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–820. - PubMed
    1. Assmann G, et al. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation. 1999;100:1930–1938. - PubMed
    1. Cullen P, von Eckardstein A, Souris S, Schulte H, Assmann G. Dyslipidaemia and cardiovascular risk in diabetes. Diabetes Obes. Metab. 1999;1:189–198. - PubMed
    1. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW. Diabetic retinopathy. More than meets the eye. Surv. Ophthalmol. 2002;47(Suppl. 2):S253–S262. - PubMed